Solvay Subsidiary Reaches Settlement on PFAS Remediation in New Jersey
By Giulia Petroni
Solvay's U.S. specialty polymers subsidiary has reached a settlement with the New Jersey Department of Environmental Protection, resolving claims related to toxic chemicals.
The Belgian chemicals company said Wednesday that Solvay Specialty Polymers USA will pay $75 million for natural resource damages and $100 million to fund remediation projects in areas near its West Deptford site. The claims involve perfluoroalkyl and polyfluoroalkyl substances, known as PFAS.
As a results of the settlement, Solvay will increase its current provision by around $250 million at the end of the second quarter, with $175 million cash out in 2024 and the balance over a 30-year period.
In the third quarter of last year, the company recorded 93 million euros ($101.9 million) of environmental provisions that reflected the estimated cost of remediation activities in New Jersey over the next 20 years.
The agreement, which is not an admission of liability, will be presented to the U.S. Court for review and approval later this year, according to the company.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
June 28, 2023 12:18 ET (16:18 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
How to Invest Like Warren Buffett
-
Cognizant Earnings: Improved Profitability Buttresses Results as Customer Spending Remains Muted
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?